Jeff Jonas
Stock Analyst at Gabelli
(n/a)
# 4,864
Out of 4,988 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Jeff Jonas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics | Initiated Coverage: Buy | $8 | $1.85 | +332.43% | 1 | Jun 15, 2026 | |
| ACH Accendra Health | Downgraded: Hold | n/a | $0.8897 | n/a | 1 | Feb 8, 2012 | |
| ANGO AngioDynamics | Upgraded: Hold | n/a | $15.44 | n/a | 1 | Feb 1, 2012 | |
| BSX Boston Scientific | Reiterated: Hold | n/a | $43.34 | n/a | 1 | Mar 16, 2010 | |
| MDT Medtronic | Reiterated: Hold | n/a | $92.13 | n/a | 1 | Mar 16, 2010 |
Acrivon Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.85
Upside: +332.43%
Accendra Health
Feb 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $0.8897
Upside: n/a
AngioDynamics
Feb 1, 2012
Upgraded: Hold
Price Target: n/a
Current: $15.44
Upside: n/a
Boston Scientific
Mar 16, 2010
Reiterated: Hold
Price Target: n/a
Current: $43.34
Upside: n/a
Medtronic
Mar 16, 2010
Reiterated: Hold
Price Target: n/a
Current: $92.13
Upside: n/a